T42

MORPHOLINO-DIPHENYLALANINE-METHOXYPROPYLBORONIC ACID

Created:	1999-07-08
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where T42 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	81
Chiral Atom Count	3
Bond Count	84
Aromatic Bond Count	17

2D diagram of T42

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	MORPHOLINO-DIPHENYLALANINE-METHOXYPROPYLBORONIC ACID
Systematic Name (OpenEye OEToolkits)	[(1R)-1-[[1-[(2R)-2-[[(S)-hydroxy(morpholin-4-yl)methyl]amino]-3,3-diphenyl-propanoyl]pyrrol-2-yl]carbonylamino]-4-methoxy-butyl]boronic acid
Formula	C₃₀ H₃₉ B N₄ O₇
Molecular Weight	578.464
Type	PEPTIDE-LIKE

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(NC(B(O)O)CCCOC)c1cccn1C(=O)C(NC(O)N2CCOCC2)C(c3ccccc3)c4ccccc4
SMILES	CACTVS	3.370	COCCC[CH](NC(=O)c1cccn1C(=O)[CH](N[CH](O)N2CCOCC2)C(c3ccccc3)c4ccccc4)B(O)O
SMILES	OpenEye OEToolkits	1.7.0	B(C(CCCOC)NC(=O)c1cccn1C(=O)C(C(c2ccccc2)c3ccccc3)NC(N4CCOCC4)O)(O)O
Canonical SMILES	CACTVS	3.370	COCCC[C@H](NC(=O)c1cccn1C(=O)[C@H](N[C@H](O)N2CCOCC2)C(c3ccccc3)c4ccccc4)B(O)O
Canonical SMILES	OpenEye OEToolkits	1.7.0	B([C@H](CCCOC)NC(=O)c1cccn1C(=O)[C@@H](C(c2ccccc2)c3ccccc3)N[C@@H](N4CCOCC4)O)(O)O
InChI	InChI	1.03	InChI=1S/C30H39BN4O7/c1-41-19-9-15-25(31(39)40)32-28(36)24-14-8-16-35(24)29(37)27(33-30(38)34-17-20-42-21-18-34)26(22-10-4-2-5-11-22)23-12-6-3-7-13-23/h2-8,10-14,16,25-27,30,33,38-40H,9,15,17-21H2,1H3,(H,32,36)/t25-,27+,30-/m0/s1
InChIKey	InChI	1.03	DTJORIMAIDQZOF-NSROOHRNSA-N

Related Resource References

Resource Name	Reference
PubChem	5289430

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.